Quest Diagnostics Income from Continuous Operations 2010-2024 | DGX

Quest Diagnostics income from continuous operations for the twelve months ending September 30, 2024 was $890M, a 8.67% increase year-over-year.

  • Quest Diagnostics annual income from continuous operations for 2023 was $0.908B, a 10.54% decline from 2022.
  • Quest Diagnostics annual income from continuous operations for 2022 was $1.015B, a 51.2% decline from 2021.
  • Quest Diagnostics annual income from continuous operations for 2021 was $2.08B, a 38.76% increase from 2020.

Quest Diagnostics Income from Continuous Operations 2010-2024 | DGX

  • Quest Diagnostics annual income from continuous operations for 2023 was $0.908B, a 10.54% decline from 2022.
  • Quest Diagnostics annual income from continuous operations for 2022 was $1.015B, a 51.2% decline from 2021.
  • Quest Diagnostics annual income from continuous operations for 2021 was $2.08B, a 38.76% increase from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.6B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.3B
Elanco Animal Health (ELAN)$7.2B
RadNet (RDNT)$5.3B
Option Care Health (OPCH)$3.9B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.9B
Astrana Health (ASTH)$2.9B
Addus HomeCare (ADUS)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$227M
Daxor (DXR)$45M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$13M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M